Proinflammatory microglia within the tumor microenvironment of IDH-mutant GBM from untreated patients were also detected in treated patients with IDH-mutant GBM, correlating the general proinflammatory status of these GBMs with prolonged survival [31]. The gene discussed is IDH1; the disease is glioblastoma.